These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38115191)

  • 1. Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approach.
    Kumar A; Dutt M; Dehury B; Sganzerla Martinez G; Swan CL; Kelvin AA; Richardson CD; Kelvin DJ
    J Biomol Struct Dyn; 2023 Dec; ():1-15. PubMed ID: 38115191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach.
    Hakami AR
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational screening of natural products to identify potential inhibitors for human neuropilin-1 (NRP1) receptor to abrogate the binding of SARS-CoV-2 and host cell.
    Karkashan A; Attar R
    J Biomol Struct Dyn; 2023 Nov; 41(19):9987-9996. PubMed ID: 36437796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
    Ebrahimi M; Karami L; Alijanianzadeh M
    Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An
    Bahadur Gurung A; Ajmal Ali M; Elshikh MS; Aref I; Amina M; Lee J
    Saudi J Biol Sci; 2022 Jun; 29(6):103297. PubMed ID: 35475118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach.
    Mathew SM; Benslimane F; Althani AA; Yassine HM
    Qatar Med J; 2021; 2021(1):12. PubMed ID: 34604010
    [No Abstract]   [Full Text] [Related]  

  • 7. Exploring the binding capacity of lactic acid bacteria derived bacteriocins against RBD of SARS-CoV-2 Omicron variant by molecular simulations.
    Erol I; Kotil SE; Ortakci F; Durdagi S
    J Biomol Struct Dyn; 2023 Dec; 41(20):10774-10784. PubMed ID: 36591650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conducting the RBD of SARS-CoV-2 Omicron Variant with Phytoconstituents from
    Hassan HA; Hassan AR; Mohamed EAR; Al-Khdhairawi A; Karkashan A; Attar R; Allemailem KS; Al Abdulmonem W; Shimizu K; Abdel-Rahman IAM; Allam AE
    Molecules; 2022 May; 27(9):. PubMed ID: 35566281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.
    Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C
    Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation.
    Sabzian-Molaei F; Hosseini S; Alipour A; Ghaderi H; Fotouhi-Chahouki F; Hadi A; Shahsavarani H
    Phytomedicine; 2023 Mar; 111():154648. PubMed ID: 36681052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations of the spike trimeric ectodomain of the SARS-CoV-2 Omicron variant: structural relationships with infectivity, evasion to immune system and transmissibility.
    de Souza AS; Amorim VMF; de Souza RF; Guzzo CR
    J Biomol Struct Dyn; 2023 Nov; 41(19):9326-9343. PubMed ID: 36345794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
    Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
    J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern.
    Chinnadurai RK; Ponne S; Chitra L; Kumar R; Thayumanavan P; Subramanian B
    Mol Divers; 2023 Dec; 27(6):2741-2766. PubMed ID: 36547813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike.
    Kehinde IA; Egbeyemi A; Kaur M; Onyenaka C; Adebusuyi T; Olaleye OA
    J Biomol Struct Dyn; 2023 Apr; 41(7):2992-3001. PubMed ID: 35220925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the mechanism of interaction of SARS-CoV-2 B.1.640.2 variant RBD with the host receptors hACE2 and GRP78.
    Shafiq A; Khalid U; Abdur Rehman U; Abdullah Almuqri E; Muddassir M; Ahmad S; Khan MI; Khan A; Wei DQ
    J Biomol Struct Dyn; 2024; 42(4):2034-2042. PubMed ID: 37286365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CL
    Jha RK; Khan RJ; Parthiban A; Singh E; Jain M; Amera GM; Singh RP; Ramachandran P; Ramachandran R; Sachithanandam V; Muthukumaran J; Singh AK
    J Biomol Struct Dyn; 2022; 40(24):13392-13411. PubMed ID: 34644249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
    Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
    Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.